Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Geriatric Depression with White Matter Changes
NCT00918684Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Dec 2002
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Weill Cornell Medicine. Started Dec 2002; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00918684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918684.